Delek US (NYSE: DK) director ends 10b5-1 plan with 200K-share sale
Rhea-AI Filing Summary
Delek US Holdings, Inc. director Ezra Uzi Yemin, through Yemin Investments, LP, reported open-market sales of an aggregate 200,000 shares of common stock on 2026-08-13. The shares were sold in multiple trades at weighted average prices of $65.75, $66.64, $67.74 and $68.27 per share, each representing numerous transactions within disclosed price ranges, pursuant to a Rule 10b5-1 trading plan that has now been completed. Following these transactions, Yemin reports 213,717 shares of Delek US common stock held directly.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary 10b5-1
Net Seller: 200,000 shares
Net Sell
5 txns
Insider
Yemin Ezra Uzi
Role
Director
Sold
200,000 shs ($13.50M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F2 | 17,566 | $65.75 | $1.15M |
| Sale | Common Stock F1, F3 | 38,388 | $66.64 | $2.56M |
| Sale | Common Stock F1, F4 | 82,224 | $67.74 | $5.57M |
| Sale | Common Stock F1, F5 | 61,822 | $68.27 | $4.22M |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 247,795 shares (Indirect, By Yemin Investments, LP);
Common Stock — 213,717 shares (Direct)
Footnotes (5)
- F1. This transaction was made pursuant to a 10b5-1 plan and is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). These transactions complete this plan.
- F2. This price reflects the weighted average sale price of multiple transactions ranging from a low sale price of $65.15 per share to a high sale price of $66.13 per share. Upon the written request of the SEC, the Issuer or a security holder of the Issuer, the reporting person agrees to provide the number of shares sold at each sale price.
- F3. This price reflects the weighted average sale price of multiple transactions ranging from a low sale price of $66.15 per share to a high sale price of $67.13 per share. Upon the written request of the SEC, the Issuer or a security holder of the Issuer, the reporting person agrees to provide the number of shares sold at each sale price.
- F4. This price reflects the weighted average sale price of multiple transactions ranging from a low sale price of $67.15 per share to a high sale price of $68.14 per share. Upon the written request of the SEC, the Issuer or a security holder of the Issuer, the reporting person agrees to provide the number of shares sold at each sale price.
- F5. This price reflects the weighted average sale price of multiple transactions ranging from a low sale price of $68.15 per share to a high sale price of $68.45 per share. Upon the written request of the SEC, the Issuer or a security holder of the Issuer, the reporting person agrees to provide the number of shares sold at each sale price.
Key Figures
Shares sold: 200,000 shares
Sale price (weighted average block 1): $65.75 per share
Sale price (weighted average block 2): $66.64 per share
+3 more
6 metrics
Shares sold
200,000 shares
Total common shares sold on 2026-08-13 across four transactions
Sale price (weighted average block 1)
$65.75 per share
Weighted average sale price for 17,566 shares on 2026-08-13
Sale price (weighted average block 2)
$66.64 per share
Weighted average sale price for 38,388 shares on 2026-08-13
Sale price (weighted average block 3)
$67.74 per share
Weighted average sale price for 82,224 shares on 2026-08-13
Sale price (weighted average block 4)
$68.27 per share
Weighted average sale price for 61,822 shares on 2026-08-13
Direct holdings after transactions
213,717 shares
Directly held Delek US common stock reported after 2026-08-13
Key Terms
Rule 10b5-1, affirmative defense conditions, weighted average sale price
3 terms
Rule 10b5-1 regulatory
"This transaction was made pursuant to a 10b5-1 plan and is intended"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
affirmative defense conditions regulatory
"intended to satisfy the affirmative defense conditions of Rule 10b5-1(c)"
weighted average sale price financial
"This price reflects the weighted average sale price of multiple transactions"
FAQ
What insider transaction did Delek US Holdings (DK) director Ezra Uzi Yemin report?
Ezra Uzi Yemin reported selling 200,000 shares of Delek US Holdings common stock on 2026-08-13. The sales were executed indirectly through Yemin Investments, LP in multiple open-market transactions at weighted average prices in the mid-$60s per share.
Was the Delek US Holdings (DK) insider sale under a Rule 10b5-1 plan?
Yes. The filing states the transactions were made pursuant to a Rule 10b5-1 trading plan intended to satisfy Rule 10b5-1(c) affirmative defense conditions. The footnote also notes that these transactions complete this plan.
Were the Delek US Holdings (DK) insider sales executed directly or indirectly by Yemin?
The reported sales were executed indirectly through Yemin Investments, LP, which held the shares. The Form 4 identifies the ownership type as indirect, with the nature of ownership explicitly stated as “By Yemin Investments, LP.”
AI-generated analysis. How Rhea-AI works. Not financial advice.